Abstract
Ischemic and traumatic brain injuries are the major acute central nervous system disorders that need to be adequately diagnosed and treated. To find biomarkers for these acute brain injuries, plasma levels of some specialized pro-resolving mediators (SPMs, i.e., lipoxin A4 [LXA4], resolvin [Rv] E1, RvE2, RvD1 and RvD2), CD59 and interleukin (IL)-6 were measured at 0, 6, 24, 72, and 168 h after global cerebral ischemic (GCI) and traumatic brain injuries (TBI) in rats. Plasma LXA4 levels tended to increase at 24 and 72 h after GCI. Plasma RvE1, RvE2, RvD1, and RvD2 levels showed a biphasic response to GCI; a significant decrease at 6 h with a return to the levels of the sham group at 24 h, and again a decrease at 72 h. Plasma CD59 levels increased at 6 and 24 h post-GCI, and returned to basal levels at 72 h post-GCI. For TBI, plasma LXA4 levels tended to decrease, while RvE1, RvE2, RvD1, and RvD2 showed barely significant changes. Plasma IL-6 levels were significantly increased after GCI and TBI, but with different time courses. These results show that plasma LXA4, RvE1, RvE2, RvD1, RvD2, and CD59 levels display differential responses to GCI and TBI, and need to be evaluated for their usefulness as biomarkers.
References
Jun 1, 1995·Annals of Neurology·N B BeamerJ R Silberger
Apr 1, 1994·Journal of the Neurological Sciences·K FassbenderM Hennerici
Nov 1, 1995·Shock·T KossmannC Morganti-Kossmann
Aug 29, 2000·Brain Research·L C Schmued, K J Hopkins
Sep 30, 2000·Scandinavian Journal of Immunology·A VäkeväS Meri
Aug 19, 2003·The Journal of Biological Chemistry·Victor L MarcheselliNicolas G Bazan
Aug 4, 2006·Molecular Immunology·Fiona C KimberleyB Paul Morgan
Dec 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle G SouzaMauro M Teixeira
Dec 17, 2008·Current Pharmaceutical Design·Antonino TuttolomondoGiuseppe Licata
Dec 25, 2008·Annals of Neurology·Sang Won SuhRaymond A Swanson
Sep 15, 2012·Brain Research·Bo Yong ChoiSang Won Suh
Mar 6, 2013·International Journal of Biological Sciences·Li JingP Andy Li
Dec 18, 2013·Journal of Neuropathology and Experimental Neurology·David J LoaneAlan I Faden
Jul 17, 2014·Critical Care : the Official Journal of the Critical Care Forum·Ségolène MrozekThomas Geeraerts
Sep 12, 2014·Neurocritical Care·Sherry H-Y ChouUNKNOWN Participants in the International Multi-disciplinary Consensus Conference on the Multimodality Monitoring
Jan 9, 2015·American Journal of Respiratory Cell and Molecular Biology·Jesmond DalliCharles N Serhan
Apr 2, 2016·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Anne E BardenTrevor A Mori
May 15, 2016·American Journal of Hypertension·Luiza O PerucciLirlândia P Sousa
Sep 16, 2016·Critical Care : the Official Journal of the Critical Care Forum·Imo P AisikuClaudia S Robertson
Oct 11, 2017·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Hernan A BazanSong Hong
May 24, 2018·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Anne BardenTrevor A Mori
Nov 30, 2018·Cells·Dae Ki HongSang Won Suh
Feb 8, 2019·Translational Research : the Journal of Laboratory and Clinical Medicine·Bo Young ChoiSang Won Suh
Jan 1, 2018·The Turkish Journal of Pediatrics·Fatih DilekNermin Güler